Pelago Bioscience

Solna, Sweden Founded: 2013 • Age: 13 yrs
Drug-target interactions are quantified via specialized assay services.
Request Access

About Pelago Bioscience

Pelago Bioscience is a company based in Solna (Sweden) founded in 2013.. Pelago Bioscience offers products and services including CETSA Services, Target Discovery, and Lead Optimization. Pelago Bioscience operates in a competitive market with competitors including Anabios, Kiyatec, Cellply, Lucid Scientific and CytoTronics, among others.

  • Headquarter Solna, Sweden
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Pelago Bioscience Ab
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Pelago Bioscience

Pelago Bioscience offers a comprehensive portfolio of products and services, including CETSA Services, Target Discovery, and Lead Optimization. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Technology for assessing cellular target engagement in drug discovery

Services for identifying and validating drug targets

Processes for enhancing drug candidate potency and selectivity

People of Pelago Bioscience
Headcount 10-50
Employee Profiles 8
Employee Profiles
People
Cindy Cázares-Körner
Head Of Lab Operations
People
Michael Dabrowski
CEO
People
Kia Pedersen
Chief Operating Officer
People
Ulla Sundberg
Key Account Manager

Unlock access to complete

Funding Insights of Pelago Bioscience

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round

    (01 Jan 2017)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2023 Amount Seed - Pelago Bioscience Valuation Impilo
Jan, 2017 Amount Grant - Pelago Bioscience Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Pelago Bioscience

Pelago Bioscience has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and Impilo. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Impilo is focused on healthcare investments in Nordic regions.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Pelago Bioscience

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Pelago Bioscience

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Pelago Bioscience Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Pelago Bioscience

Pelago Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Anabios, Kiyatec, Cellply, Lucid Scientific and CytoTronics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Ex-vivo human tissue studies are performed for preclinical drug discovery.
domain founded_year HQ Location
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
domain founded_year HQ Location
Developer of in-vitro diagnostic products for the detection of cancer
domain founded_year HQ Location
Real-time cell analyzers are developed for oxygen consumption monitoring.
domain founded_year HQ Location
Cell-based assays for drug discovery are developed via CMOS platform.
domain founded_year HQ Location
Develops cell-based assays and provides services for drug discovery and development.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Pelago Bioscience

Frequently Asked Questions about Pelago Bioscience

When was Pelago Bioscience founded?

Pelago Bioscience was founded in 2013 and raised its 1st funding round 4 years after it was founded.

Where is Pelago Bioscience located?

Pelago Bioscience is headquartered in Solna, Sweden.

What does Pelago Bioscience do?

Pelago Bioscience was founded in 2013 in Solna, Sweden, and operates within the biotechnology sector focused on drug discovery. Assay services based on Cellular Thermal Shift Assay (CETSA) technology are provided to measure drug-target interactions in situ. These support preclinical and clinical development through three formats: CETSA Classics using western blot detection, CETSA HT with plate-based fluorescence, and CETSA MS enabling mass spectrometry analysis of up to 6000 proteins.

Who are the top competitors of Pelago Bioscience?

Pelago Bioscience's top competitors include Metrion Biosciences, CytoTronics and Kiyatec.

What products or services does Pelago Bioscience offer?

Pelago Bioscience offers CETSA Services, Target Discovery, and Lead Optimization.

Who are Pelago Bioscience's investors?

Pelago Bioscience has 2 investors. Key investors include European Union, and Impilo.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available